By Ross Todd | July 22, 2022
New York's Appellate Division, First Department sided with Josh Rosenkranz, Bob Loeb and Naomi Scotten of Orrick, Herrington & Sutcliffe ruling that trial evidence did not support a finding that talc caused a Brooklyn woman's cancer.
By Ross Todd | June 28, 2022
A judge in New Orleans granted a temporary restraining order initially blocking Louisiana's so-called "trigger laws," designed to make abortion illegal in the state immediately upon the reversal of Roe v. Wade.
By Ross Todd | May 5, 2022
Paul Coggins of Locke Lord and Fort Worth criminal defense attorney Brian Poe talk about defending a bellwether federal wage-fixing case targeting two former officials at a Texas physical therapy company.
By Ross Todd | April 26, 2022
In the core team of 20 lawyers in the firm's product liability and mass torts practice, Sidley reports 90% of the partners are women as well as more than 80% of associates.
By Ross Todd | April 22, 2022
Lawyers at Morgan Lewis and Wilmer represent the Denver-based dialysis company and a team from Winston & Strawn, Fish & Richardson and McDermott represent former CEO Kent Thiry. A federal jury this week acquitted the defendants on all counts of conspiring with three companies run by DaVita alumni to avoid competing for employees.
Litigation Daily | Best Practices
By Ross Todd | April 14, 2022
"I'll suggest to you that you are not trying to persuade the jury any less in opening statements than you are in closing arguments. It's just that you have to do so within the confines of the rules of evidence and the rules of procedure and the rules of ethics," says Chicago trial lawyer Dan Kotin.
By Ross Todd | March 14, 2022
Lori Cohen and William Michael Jr., the co-chairs of Greenberg's trial practice group, discuss the details of the 100-plus lawyer boutique-within-a-firm.
By Ross Todd | December 7, 2021
Brown, who has put together a string of jury wins for J&J in talc trials, says jurors are putting a premium on their own time.
By Ross Todd | November 19, 2021
Barbara Mullin of Patterson Belknap Webb & Tyler fended off a generic drug maker's patent challenge to Janssen's antipsychotic drug Invega Sustenna which has more than $1.5 billion in annual sales. The win means nearly 10 more years of patent protection for the drug.
By Ross Todd | November 2, 2021
During a virtual fireside chat Monday, two Morrison & Foerster lawyers dug into the question of whether lawyers for the former Theranos CEO will call an expert on intimate partner abuse to try to make the case she was controlled by her former boyfriend and business partner, who is set to be tried separately next year.
Presented by BigVoodoo
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Truly exceptional Bergen County New Jersey Law Firm is growing and seeks strong plaintiff's personal injury Attorney with 5-7 years plaintif...
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS